About Hydra Active Pharma Sciences Private Limited
Data last updated:
Hydra Active Pharma Sciences Private Limited is a private limited company based in Bangalore, Karnataka, India, a subsidiary of Ramanagaram Enterprises Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U74999KA2016PTC197435. Its GSTIN is 29AAGCT0124P1Z1 (Karnataka). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹146 Cr and a paid-up capital of ₹121.05 Cr. It was formerly known as Tenshi Active Pharma Sciences Private Limited and Tenshi Active Pharma Sciences Limited. It is led by directors Ramaprasad Jyothinagaravyasha Sriraman and Chandrappa Seetharamaiah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.97 Cr, a growth of 41% compared to the previous year. For the same year it recorded a net profit of ₹1.21 Cr (net margin 61.2%) and EBITDA of -₹36 Lakh (EBITDA margin -18.2%). Revenue has grown at a compounded annual rate (CAGR) of 31% over three years and 64% over five years.
The company is associated with 2 brands: Aurore Life Sciences and Tenshi Life Sciences. As per MCA filings, the company has open charges of ₹300 Cr and satisfied charges of ₹160 Cr on record. Court records list 8 cases involving the company, including 8 filed against it; 3 cases are pending. The company has 21 deals on record (11 secondary share transfers, 5 funding rounds, 3 rights issues), with disclosed funding of ₹52.25 Cr; the latest was in March 2022. Its 9 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 4 smaller; the largest is G S Pharmbutor Private Limited with revenue of ₹561.56 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tenshi.co.in.
Company details
Name history
Hydra Active Pharma Sciences has undergone 2 name changes throughout its history. The company was previously known as Tenshi Active Pharma Sciences Private Limited, and Tenshi Active Pharma Sciences Limited. The current legal name is Hydra Active Pharma Sciences Private Limited.
| Company Name | Status |
|---|---|
| Hydra Active Pharma Sciences Private Limited | Current |
| Tenshi Active Pharma Sciences Private Limited | Previous |
| Tenshi Active Pharma Sciences Limited | Previous |
CIN history
Hydra Active Pharma Sciences has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U74999KA2016PTC197435, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74999KA2016PTC197435 | Current |
| U74999KA2016PTC098276 | Previous |
| U74999MH2016PTC365641 | Previous |
| U74999KA2016PLC098276 | Previous |
Contact details
Hydra Active Pharma Sciences Private Limited's registered office is in Bangalore, Karnataka.
- Social Media
- Registered AddressKaruna House 1st Floor Sy. No. 152/6 And 154/16, Dorasani Palya Begur Hobli, Bangalore, Karnataka, India – 560076
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Hydra Active Pharma Sciences operates two associated brands: Aurore Life Sciences and Tenshi Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops and produces Active Pharmaceutical Ingredients and intermediates for pharmaceutical markets. | aurorels.com | |
| Delivers advanced finished dosage pharmaceuticals using global infrastructure and quality systems. | tenshi.co.in |
Financials of Hydra Active Pharma Sciences Private Limited
FY 2025 filings availableHydra Active Pharma Sciences Private Limited reported revenue of ₹1.97 Cr (up 41% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 64% over five years, including 41% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹1.97 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹36 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.21 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -18.2% | ||||
| Net Profit Margin | 61.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hydra Active Pharma Sciences Private Limited, buy the company report.
Board of directors of Hydra Active Pharma Sciences Private Limited
Hydra Active Pharma Sciences has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramaprasad Jyothinagaravyasha Sriraman | Director | 06 Dec 2016 | 9 Years 10 Months | Current |
| Chandrappa Seetharamaiah | Director | 31 Dec 2020 | 5 Years 9 Months | Current |
Peer comparison
Hydra Active Pharma Sciences Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| G S Pharmbutor Private Limited | ₹561.56 Cr (FY 2025) | 6.0% | Rudrapur, Uttarakhand, India | |||
| Ind Swift Limited | ₹560.24 Cr (FY 2024) | 33.0% | Chandigarh, India | |||
| Shalina Laboratories Private Limited | ₹551.12 Cr (FY 2023) | -1.0% | Mumbai, Maharashtra, India | |||
| German Remedies Pharmaceuticals Private Limited | ₹546.98 Cr (FY 2025) | 9.0% | Ahmedabad, Gujarat, India | |||
| Graviti Pharmaceuticals Private Limited | ₹543.75 Cr (FY 2025) | 17.0% | Hyderabad, Telangana, India | |||
| Kusum Healthcare Private Limited | ₹537.89 Cr (FY 2025) | 10.0% | New Delhi, Delhi, India | |||
| Unison Pharmaceuticals Private Limited | ₹537.1 Cr (FY 2025) | 23.0% | Ahmedabad, Gujarat, India | |||
| Maneesh Pharmaceuticals Limited | ₹534.48 Cr (FY 2022) | 28.0% | Mumbai, Maharashtra, India | |||
| Mapaex Health and Personalcare Private Limited | ₹514.15 Cr (FY 2024) | 23.0% | Bhopal, Madhya Pradesh, India | |||
| Hydra Active Pharma Sciences Private Limitedthis company | ₹1.97 Cr (FY 2023) | ₹1.21 Cr | 61.2% | 41.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Hydra Active Pharma Sciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Sep 2024 | 100993853 | Others | ₹300 Cr | Open | |
| 28 Jun 2024 | 100961927 | Others | ₹40 Cr | Satisfied | |
| 11 Jan 2024 | 100914769 | Others | ₹25 Cr | Satisfied | |
| 11 Jan 2024 | 100914767 | Others | ₹25 Cr | Satisfied | |
| 11 Jan 2024 | 100876303 | Others | ₹35 Cr | Satisfied |
To see the full charge records of Hydra Active Pharma Sciences Private Limited, buy the company report.
Total charge records: 6 View all charges
Deals & funding
Hydra Active Pharma Sciences Private Limited has 21 deals on record (11 secondary share transfers, 5 funding rounds, 3 rights issues), with disclosed funding of ₹52.25 Cr; the latest was in March 2022.
Deals on record (5 of 21)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: Tenshi Life Sciences Private Limited Seller: Chayadeep Properties Private Limited |
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: Nimbha Biotech Private Limited Seller: Ilabs Group |
| Aug 2021 | Secondary share transfer | Undisclosed | Buyer: Spiracca Ventures LLP , an individual Seller: Agnus Capital |
| Jul 2021 | Secondary share transfer | Undisclosed | Buyer: Spiracca Ventures LLP Seller: Agnus Capital |
| Jun 2021 | Secondary share transfer | Undisclosed | Buyer: Chayadeep Properties Private Limited , Tenshi Life Sciences Private Limited Seller: Ilabs Group |
To see the full deal history of Hydra Active Pharma Sciences Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Hydra Active Pharma Sciences Private Limited has 8 court cases on record: 8 filed against it. 3 cases are pending and 5 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLAT | 6 | 6 | 3 |
| High courts | 1 | 1 | 0 |
| NCLT | 1 | 1 | 0 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLAT, Court III | Tribunal matter | Filed against the company by Aurore Life Sciences Private Limited | Pending |
| NCLAT, NCLAT New Delhi | Interim or miscellaneous application | Filed against the company by Aurore Life Sciences Private Limited | Pending |
| NCLAT, NCLAT Chennai | Court case (TA (AT)) | Filed against the company by Aurore Life Sciences Private Limited | Disposed |
| NCLAT, NCLAT Chennai | Insolvency matter | Filed against the company by an individual | Disposed |
| NCLAT, NCLAT Chennai | Interim or miscellaneous application | Filed against the company by an individual | Disposed |
To see the full case history of Hydra Active Pharma Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hydra Active Pharma Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Hydra Active Pharma Sciences has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAGCT0124P1Z1 | Karnataka | Active | 01 Dec 2017 |
To see the full GST registrations and return filing status of Hydra Active Pharma Sciences Private Limited, buy the company report.
Recent activity
Hydra Active Pharma Sciences Private Limited has 5 board changes on record since 2016: 2 appointments and 3 cessations. The latest: Geethika Jayasree ceased to be Company Secretary on 05 Jun 2025.
7 earlier events are in the company report.
Frequently asked questions
Hydra Active Pharma Sciences is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 December 2016 (10+ years old) and is registered under CIN U74999KA2016PTC197435.
Hydra Active Pharma Sciences has 2 current directors:
- Ramaprasad Jyothinagaravyasha Sriraman - Director
- Chandrappa Seetharamaiah - Director
The latest financial statements of Hydra Active Pharma Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Hydra Active Pharma Sciences is 29AAGCT0124P1Z1, registered in Karnataka. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Hydra Active Pharma Sciences is U74999KA2016PTC197435. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hydra Active Pharma Sciences has 8 court cases on record: 8 filed against it. 3 are pending. Most are in the nclat.
Hydra Active Pharma Sciences was incorporated on 06 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Bangalore.
Hydra Active Pharma Sciences has 21 deals on record (11 secondary share transfers, 5 funding rounds, 3 rights issues), with disclosed funding of ₹52.25 Cr; the latest was in March 2022.
The peers of Hydra Active Pharma Sciences by revenue are G S Pharmbutor Private Limited, Ind Swift Limited, Shalina Laboratories Private Limited, German Remedies Pharmaceuticals Private Limited, Graviti Pharmaceuticals Private Limited and 4 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Geethika Jayasree ceased to be Company Secretary on 05 Jun 2025. Pudhucode Radhakrishnan Kannan ceased to be Director on 28 Jan 2021. Chandrappa Seetharamaiah was appointed as Director on 31 Dec 2020. Hydra Active Pharma Sciences has 5 board changes on record in total.
Hydra Active Pharma Sciences can be reached through the website tenshi.co.in. Its registered office is in Bangalore, Karnataka, India.